drugset / Trial / NCT00144560

Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)

NCT00144560

Completed 31 enrolled Chugai Pharmaceutical
RandomizedSingle-groupOpen-labelTreatment

Summary

This is an open-label, clinical pharmacology study to investigate drug-drug interaction in patients with RA.

Timeline

Start
2005-02
Primary completion
2005-08
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Tocilizumab Monoclonal antibody

Indications